Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), a late-stage biotechnology developing impactful treatments for neuropsychiatric ...
Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 ...
Brea Schmidt, Gregg Behr and Latoya Wilson joined us for our Talk Parent Panel to talk about some of the pressures parents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback